Skip to main content
Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
2.940
+0.170 (6.14%)
At close: Nov 11, 2026, 4:00 PM EST
2.940
0.00 (0.00%)
Pre-market: Nov 12, 2026, 6:42 AM EST

Liminatus Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4178075349337
Market Cap Growth
-87.48%-79.39%6.12%-78.38%3.48%-
Enterprise Value
2179789--
Last Close Price
2.9430.50561.00516.50506.00489.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
10.95-1.68-4.14-4.78-32.30-29.64

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
4.80-0.15-1.03-1.02-1.53-1.16
Net Debt / Equity Ratio
-5.24-0.11-1.03-0.99-1.06-1.16
Net Debt / EBITDA Ratio
0.39-0.37---4.23-3.30
Net Debt / FCF Ratio
0.40-0.11-13.73-4.67-13.18-78.47
Quick Ratio
0.990.030.000.030.290.00
Current Ratio
1.120.050.210.120.390.19
Return on Assets (ROA)
-95.65%-62.65%-54.41%-66.30%-35.51%-
Return on Capital Employed (ROCE)
-1119.00%30.30%17.20%30.50%25.10%35.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-614.31%-61.82%-4.43%-6.60%-0.84%-1.66%
FCF Yield
-100.93%-60.43%-1.81%-4.43%-0.25%-0.05%
Buyback Yield / Dilution
-82.95%-35.73%82.93%-188.25%--
SEC Filings: 10-K · 10-Q